US 8552002 — Patent Expiration

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US8552002

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 8552002

Compounds And Compositions As Protein Kinase Inhibitors

High Confidence

Application No. 11570983

August 25, 2029

3y 67d remaining

Could not fetch continuity data for application PCTEP2005006815: Resource not found (404)

Earliest effective filing

Jun 23, 2005

+ 20 years

Jun 23, 2025

PTA +1524d

Aug 25, 2029

No TD

—

Final

Aug 25, 2029

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

October 15, 2008

Earliest Effective Filing

June 23, 2005

Issue Date

October 8, 2013

PTA

+1524 days

Base Expiry (before PTA)

June 23, 2025

June 23, 2005 + 20 years = June 23, 2025 + 1524 PTA days = August 25, 2029

National Stage Entry of application PCTEP2005006815, filed Jun 23, 2005

PRO

60582425 — Provisional — not used for base term

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.